IVF Quote, Financials, Valuation and Earnings

Nutriband has a net margin of -1063.02% compared to INVO Fertility's net margin of -208.09%. INVO Fertility's return on equity of -714.24% beat Nutriband's return on equity of -102.63%.

INVO Fertility has a consensus price target of --, signalling upside risk potential of 631.8%. On the other hand Nutriband has an analysts' consensus of $15.00 which suggests that it could grow by 84.73%. Given that INVO Fertility has higher upside potential than Nutriband, analysts believe INVO Fertility is more attractive than Nutriband.

INVO Fertility has a beta of 2.045, which suggesting that the stock is 104.471% more volatile than S&P 500. In comparison Nutriband has a beta of 1.226, suggesting its more volatile than the S&P 500 by 22.565%.

INVO Fertility has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. INVO Fertility pays -- of its earnings as a dividend. Nutriband pays out -- of its earnings as a dividend.

INVO Fertility quarterly revenues are $1.6M, which are larger than Nutriband quarterly revenues of $667.4K. INVO Fertility's net income of -$17.4M is lower than Nutriband's net income of -$1.4M. Notably, INVO Fertility's price-to-earnings ratio is -- while Nutriband's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for INVO Fertility is 0.08x versus 37.58x for Nutriband. Usually stocks with elevated PS ratios are considered overvalued.

enVVeno Medical has a net margin of -1063.02% compared to INVO Fertility's net margin of --. INVO Fertility's return on equity of -714.24% beat enVVeno Medical's return on equity of --.

INVO Fertility has a consensus price target of --, signalling upside risk potential of 631.8%. On the other hand enVVeno Medical has an analysts' consensus of $12.50 which suggests that it could grow by 192.74%. Given that INVO Fertility has higher upside potential than enVVeno Medical, analysts believe INVO Fertility is more attractive than enVVeno Medical.

INVO Fertility has a beta of 2.045, which suggesting that the stock is 104.471% more volatile than S&P 500. In comparison enVVeno Medical has a beta of 0.932, suggesting its less volatile than the S&P 500 by 6.781%.

INVO Fertility has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. enVVeno Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. INVO Fertility pays -- of its earnings as a dividend. enVVeno Medical pays out -- of its earnings as a dividend.

INVO Fertility quarterly revenues are $1.6M, which are larger than enVVeno Medical quarterly revenues of --. INVO Fertility's net income of -$17.4M is lower than enVVeno Medical's net income of -$4.5M. Notably, INVO Fertility's price-to-earnings ratio is -- while enVVeno Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for INVO Fertility is 0.08x versus 416.56x for enVVeno Medical. Usually stocks with elevated PS ratios are considered overvalued.

SINTX Technologies has a net margin of -1063.02% compared to INVO Fertility's net margin of -787.63%. INVO Fertility's return on equity of -714.24% beat SINTX Technologies's return on equity of -180.99%.

INVO Fertility has a consensus price target of --, signalling upside risk potential of 631.8%. On the other hand SINTX Technologies has an analysts' consensus of $28.00 which suggests that it could grow by 910.83%. Given that SINTX Technologies has higher upside potential than INVO Fertility, analysts believe SINTX Technologies is more attractive than INVO Fertility.

INVO Fertility has a beta of 2.045, which suggesting that the stock is 104.471% more volatile than S&P 500. In comparison SINTX Technologies has a beta of 0.713, suggesting its less volatile than the S&P 500 by 28.749%.

INVO Fertility has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SINTX Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. INVO Fertility pays -- of its earnings as a dividend. SINTX Technologies pays out -- of its earnings as a dividend.

INVO Fertility quarterly revenues are $1.6M, which are larger than SINTX Technologies quarterly revenues of $291K. INVO Fertility's net income of -$17.4M is lower than SINTX Technologies's net income of -$2.3M. Notably, INVO Fertility's price-to-earnings ratio is -- while SINTX Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for INVO Fertility is 0.08x versus 2.66x for SINTX Technologies. Usually stocks with elevated PS ratios are considered overvalued.

Beyond Air has a net margin of -1063.02% compared to INVO Fertility's net margin of -697.4%. INVO Fertility's return on equity of -714.24% beat Beyond Air's return on equity of -218.07%.

INVO Fertility has a consensus price target of --, signalling upside risk potential of 631.8%. On the other hand Beyond Air has an analysts' consensus of $2.25 which suggests that it could grow by 1288.89%. Given that Beyond Air has higher upside potential than INVO Fertility, analysts believe Beyond Air is more attractive than INVO Fertility.

INVO Fertility has a beta of 2.045, which suggesting that the stock is 104.471% more volatile than S&P 500. In comparison Beyond Air has a beta of 0.221, suggesting its less volatile than the S&P 500 by 77.879%.

INVO Fertility has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Beyond Air offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. INVO Fertility pays -- of its earnings as a dividend. Beyond Air pays out -- of its earnings as a dividend.

INVO Fertility quarterly revenues are $1.6M, which are larger than Beyond Air quarterly revenues of $1.2M. INVO Fertility's net income of -$17.4M is lower than Beyond Air's net income of -$8M. Notably, INVO Fertility's price-to-earnings ratio is -- while Beyond Air's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for INVO Fertility is 0.08x versus 2.96x for Beyond Air. Usually stocks with elevated PS ratios are considered overvalued.